Page last updated: 2024-10-30

lomustine and Charcot-Marie-Tooth Disease

lomustine has been researched along with Charcot-Marie-Tooth Disease in 1 studies

Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernstock, JD1
Cohen, JL1
Singh, S1
Schlappi, CW1
Fiveash, JB1
Johnston, JM1
Fequiere, P1
Orr, BA1
Li, R1
Friedman, GK1

Other Studies

1 other study available for lomustine and Charcot-Marie-Tooth Disease

ArticleYear
Treatment-induced remission of medulloblastoma using a chemotherapeutic regimen devoid of vincristine in a child with Charcot-Marie-Tooth disease.
    Current oncology (Toronto, Ont.), 2019, Volume: 26, Issue:2

    Topics: Antineoplastic Agents; Carboplatin; Cerebellar Neoplasms; Charcot-Marie-Tooth Disease; Chemoradiothe

2019
chemdatabank.com